• Product NameSildenafil citrate
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivitySildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), is a well-tolerated and highly effective treatment for erectile dysfunction.
• Target NamePDE inhibitor
• CAS No. 171599-83-0
• Calculated MW 666.7
• Formulation C28H38N6O11S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Endocrine system
  SMILES:OC(=O)CC(O)(CC(O)=O)C(O)=O.CCCC1=NN(C)C2=C1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(C)CC1
  Pathways:Metabolism
  Receptor:PDE5; PDE6
  Boling pt:
  Melting pt:187-189C
  Solubility:DMSO: 20 mg/mL warmed (29.99 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Nehra A, et al. World J Urol, 2001, 19(1), 40-45.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting